/ pharma stocks


Novo Nordisk: Is the Ozempic Hype Train Finally Slowing Down?
/ Best Stocks, Market Analysis

Novo Nordisk: Is the Ozempic Hype Train Finally Slowing Down?

Ozempic-famed Novo Nordisk took over a $70 billion wipeout off its market value this week. Is this the beginning of a trend, or a great opportunity?

July 31, 2025
Why did Novo Nordisk’s Stock Crash Over 20% in Premarket Trading Today?

Why did Novo Nordisk’s Stock Crash Over 20% in Premarket Trading Today?

Novo Nordisk stock crashed over 20% in premarket trading after the company cut its 2025 forecast for the second time.

July 29, 2025
Why is CELC Skyrocketing in Premarket Trading Today?

Why is CELC Skyrocketing in Premarket Trading Today?

Celcuity's stock surged over 112% in premarket trading following positive Phase 3 trial results for its breast cancer treatment, marking a potential breakthrough in targeted cancer therapy.

July 28, 2025
Why did XAGE Stock Surge in Today’s Premarket Trading?

Why did XAGE Stock Surge in Today’s Premarket Trading?

XAGE stock surged over 134% in premarket trading following the announcement of an all-stock merger with THPlasma.

July 15, 2025
Why Did INKT Stock Skyrocket in Today’s Premarket Trading?

Why Did INKT Stock Skyrocket in Today’s Premarket Trading?

MiNK Therapeutics stock surged 213% in premarket trading following the publication of a landmark case study showing complete cancer remission in a patient treated with their experimental therapy ...

July 11, 2025

Get Trade Ideas and Market Insights Delivered to You Premarket - Every Day

X